background image

Paid Clinical Trials Santa Ana

Discover 3,365 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

Recruiting
PHASE1
PHASE2

Sponsor:

Ellipses Pharma

Location:

Los Angeles CA, Stanford CA, Portland OR, Seattle WAshow 12 more

Code:

NCT05443126

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

EP0031

A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.

Recruiting

Sponsor:

University College, London

Location:

Los Angeles CA, Green Bay WI, Saint Joseph MI, Detroit MIshow 4 more

Code:

NCT01792726

Conditions

Early Breast Cancer

Eligibility Criteria

Sex: Female

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Boost to the tumour bed

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Recruiting
PHASE2

Sponsor:

Pfizer

Location:

Orange CA, Garden Grove CA, Loma Linda CA, San Bernardino CAshow 14 more

Code:

NCT05287126

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Etrasimod

A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)

Recruiting
PHASE3

Sponsor:

Boston Children's Hospital

Location:

Orange CA, Los Angeles CA, Loma Linda CA, San Diego CAshow 43 more

Code:

NCT05600426

Conditions

Severe Aplastic Anemia

Eligibility Criteria

Sex: All

Age: 0 - 25

Healthy Volunteers: Not accepted

Interventions

cyclosporine

Matched Unrelated Donor Hematopoetic Stem Cell Transplant

horse anti-thymocyte globulin (ATG)

rabbit anti-thymocyte globulin (ATG)

Methotrexate

First in Human Study of TORL-3-600 in Participants With Advanced Cancer

Recruiting
PHASE1

Sponsor:

TORL Biotherapeutics, LLC

Location:

Fullerton CA, Los Angeles CA, Denver CO, Dallas TXshow 4 more

Code:

NCT05948826

Conditions

Advanced Solid Tumor

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TORL-3-600

BI-1808 As a Single Agent and with Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Recruiting
PHASE1
PHASE2

Sponsor:

BioInvent International AB

Location:

Duarte CA, Philadelphia PA

Code:

NCT04752826

Conditions

Advanced Malignancies

Ovarian Cancer

T-cell Lymphoma

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BI-1808

Pembrolizumab (KEYTRUDA® ) 25 Mg/mL Solution for Injection

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Recruiting
PHASE3

Sponsor:

Chimerix

Location:

Orange CA, Costa Mesa CA, Los Angeles CA, Santa Monica CAshow 53 more

Code:

NCT05580562

Conditions

H3 K27M

Glioma

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Dordaviprone (ONC201)

Dordaviprone (ONC201) + Placebo

Placebo

Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience

Recruiting

Sponsor:

Arrowhead Regional Medical Center

Location:

Colton CA

Code:

NCT02485262

Conditions

Hepatitis C

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sofosbuvir and simeprevir

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Recruiting
PHASE1

Sponsor:

Pfizer

Location:

Duarte CA, Aurora CO, Houston TX, Springdale ARshow 5 more

Code:

NCT06447662

Conditions

Carcinoma, Pancreatic Ductal

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07934040

Gemcitabine

Nab-paclitaxel

Cetuximab

Fluorouracil

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Recruiting
PHASE1
PHASE2

Sponsor:

Iovance Biotherapeutics, Inc.

Location:

Los Angeles CA, Westwood KS, Milwaukee WI, Louisville KYshow 6 more

Code:

NCT05361174

Conditions

Unresectable Melanoma

Metastatic Melanoma

Stage III Non-small Cell Lung Cancer

Stage IV Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

IOV-4001